Croatia power consumption - Dec 01, 2023
Serbia power consumption - Dec 01, 2023
Bulgaria power consumption - Dec 01, 2023
Croatia’s share indices extend gains thanks to Podravka, Adris
Ljubljana share indices end week up, Telekom Slovenije leads gainers
Nov 30, 2017 11:29 EEST
November 30 (SeeNews) - Bulgarian drug distributor Sopharma Trading [BUL:SO5] said its consolidated net profit fell to 7.5 million levs ($4.55 million/3.83 million euro) in the first nine months of 2017, from 8.5 million levs in the prior-year period.
The company’s revenue rose to 504.1 million levs in the period under review, from 447.9 million levs the year before, Sopharma Trading said in a bourse filing on Wednesday.
Cost of goods sold increased to 464.6 million levs in January-September, from 413.5 million levs in the corresponding period of last year.
Sopharma Trading is a unit of Bulgarian pharmaceuticals producer Sopharma [BUL:3JR].
(1 euro = 1.95583 levs)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options